Skip to main content
Theranostics logoLink to Theranostics
. 2021 Jan 1;11(4):1543–1545. doi: 10.7150/thno.55978

Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy: Erratum

Lijun Yang 2, Donglin Han 3, Qi Zhan 3, Xueping Li 3, Peipei Shan 1, Yunjie Hu 4, Han Ding 1, Yu Wang 1, Lei Zhang 1, Yuan Zhang 1, Sheng Xue 1, Jin Zhao 3, Xin Hou 3, Yin Wang 1, Peifeng Li 1, Xubo Yuan 3,, Hongzhao Qi 1,
PMCID: PMC7778593  PMID: 33408766

1. In our paper 1, the label of Figure 6C was reversed. The correct version of the figure appears below.

2. In our paper 1, the images of experimental groups in Figure S6 have misused that of the Control group. The correct version of the figure appears below.

The corrections made in this erratum do not affect the original conclusions. The authors apologize for any inconvenience or misunderstanding that this error may have caused.

Figure 6.

Figure 6

A) Effects of D-M-EXOs on serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP); B) effects of D-M-EXOs on serum levels of creatine kinase (CK), creatine kinase-MB (CK) and creatine kinase (LDH); C) histological sections of liver and heart stained with hematoxylin and eosin, the bar is 200 μm. Significance levels are shown as nsp>0.05, *p<0.05, ***p<0.005 and ****p<0.001.

Figure A.

Figure A

(Figure S6) Histological sections of major organs stained with hematoxylin and eosin. The bar is 200 μm.

References

  • 1.Yang LJ, Han DL, Zhan Q, Li XP, Shan PP, Hu YJ. et al. Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy. Theranostics. 2019;9(25):7680–9696. doi: 10.7150/thno.37220. doi:10.7150/thno.37220. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Theranostics are provided here courtesy of Ivyspring International Publisher

RESOURCES